Therapeutic Group: Glycopeptide antibiotic Presentation Tergocin 200 IM/IV Injection/Infusion: Each vial contains Teicoplanin BP 200 mg as lyophilized cake or powder. Tergocin 400 IM/IV Injection/Infusion: Each vial contains Teicoplanin BP 400 mg as lyophilized cake or powder Description Teicoplanin is a glycopeptide antibiotic that has shown in vitro bactericidal activity against both anaerobic and aerobic […]
Therapeutic Group: Oxazolidiones Presentation TezolidTM Tablet: Each tablet contains Tedizolid Phosphate INN 200 mg. TezolidTM IV Infusion: Each vial contains Tedizolid Phosphate INN 200 mg as lyophilized powder for IV infusion. Description Tedizolid is an oxazolidinone-class antibiotic indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible isolates of the […]
Therapeutic Group: Skin Presentation Tazoskin cream: Each gm Tazoskin cream contains Tazarotene INN 1mg Description Topical Tazarotene blocks ornithine decarboxylase (ODC) activity, which is associated with cell proliferation and hyperplasia. Tazarotene suppresses expression of MRP8, a marker of inflammation present in the epidermis of psoriasis patients at high levels. In human keratinocyte cultures, it inhibits […]
Therapeutic Group: Urological Presentation Prostacin Capsule: Each modified release capsule contains Tamsulosin Hydrochloride USP 0.4 mg (as modified release Pellets). Description Tamsulosin, a selective alpha1 adrenoceptor blocking agent, exhibits its selectivity for alpha1A adrenoceptors in human prostate. Blockade of these adrenoceptors can cause smooth muscle in the bladder neck and prostate to relax, resulting in […]
Therapeutic Group: Urological Presentation Tadalis 10 tablet: Each tablet contains 10 mg of Tadalafil INN. Description Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide; inhibition of PDE5 by Tadalafil produces increased levels of cGMP in the corpus cavernosum. […]
Therapeutic Group: Skin Presentation Tacrolim 0.03% Ointment: Each gram ointment contains Tacrolimus INN 300 mcg. Tacrolim 0.1% Ointment: Each gram ointment contains Tacrolimus INN 1 mg. Description Tacrolimus is a macrolide immunomodulator produced by Streptomyces tsukubaensis. It has been demonstrated that Tacrolimus inhibits T-lymphocyte activation by first binding to an intracellular protein, FKBP-12. A complex […]
Therapeutic Group: Drugs of Nervous System Presentation Somarant tablet: Each tablet contains Suvorexant INN 10 mg. Description Suvorexant a highly selective antagonist for orexin receptors OX1R and OX2R. The mechanism by which Suvorexant exerts its therapeutic effect in insomnia is presumed to be through antagonism of orexin receptors. The orexin neuropeptide signaling system is a […]
Therapeutic Group: Anti Cancer Presentation Sunicent 50: Each capsule contains Sunitinib Malate INN eq. to Sunitinib 50 mg. Description Sunitinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor. These include all receptors for platelet-derived growth factor (PDGF-Rs) and vascular endothelial growth factor receptors (VEGFRs), which play a role in both tumor angiogenesis and tumor cell […]
Therapeutic Group: Bio Tech Presentation STK Injection: Each vial contains 1 500 000 IU stabilized pure Streptokinase as lyophilized powder. Description Streptokinase is highly purified Streptokinase obtained from the culture filtrate of beta-haemolytic Streptococci of group C. Streptokinase acts with plasminogen to produce an ‘activator complex’ that converts plasminogen to the proteolytic enzyme, plasmin. The […]
Therapeutic Group: Natural Substitute of Sugar Presentation Steviol Glycoside Description Natural Substitute of Sugar Indications N/A Dosage & Administration N/A Precautions N/A Commercial Pack N/A